Antiatherosclerotic Effect and Molecular Mechanism of Salidroside
Authors:
Open Access
- 23 March 2023
- journal article
- review article
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 24 (4) , 97
Abstract
Atherosclerotic cardiovascular disease is currently the leading cause of death worldwide. Its pathophysiological basis includes endothelial dysfunction, macrophage activation, vascular smooth muscle cell (VSMC) proliferation, lipid metabolism, platelet aggregation, and changes in the gut microbiota. Salidroside has beneficial effects on atherosclerosis through multiple pathways. In this review, we present studies on the regulatory effect of salidroside on atherosclerosis. Furthermore, we report the protective effects of salidroside against atherosclerosis by ameliorating endothelial dysfunction, suppressing macrophage activation and polarization, inhibiting VSMC proliferation, adjusting lipid metabolism, attenuating platelet aggregation, and modulating the gut microbiota. This review provides further understanding of the molecular mechanism of salidroside and new ideas for atherosclerosis management.Keywords
Funding Information
- Major Technology Projects of Changzhou Health Commission (ZD202212)
This publication has 95 references indexed in Scilit:
- Macrophage phenotypes in atherosclerosisImmunological Reviews, 2014
- Salidroside blocks the proliferation of pulmonary artery smooth muscle cells induced by platelet-derived growth factor-BBMolecular Medicine Reports, 2014
- Intermittent hypoxia-induced endothelial barrier dysfunction requires ROS-dependent MAP kinase activationAmerican Journal of Physiology-Cell Physiology, 2014
- Local proliferation dominates lesional macrophage accumulation in atherosclerosisNature Medicine, 2013
- Salidroside attenuates LPS-stimulated activation of THP-1 cell-derived macrophages through down-regulation of MAPK/NF-kB signaling pathwaysCurrent Medical Science, 2013
- LOX-1, OxLDL, and AtherosclerosisMediators of Inflammation, 2013
- Salidroside Improves Homocysteine-Induced Endothelial Dysfunction by Reducing Oxidative StressEvidence-Based Complementary and Alternative Medicine, 2013
- Salidroside Decreases Atherosclerotic Plaque Formation in Low-Density Lipoprotein Receptor-Deficient MiceEvidence-Based Complementary and Alternative Medicine, 2012
- Managing adverse effects and drug–drug interactions of antiplatelet agentsNature Reviews Cardiology, 2011
- Pathogenesis of AtherosclerosisJACC, 2006